Home   >  
∨

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Epigenetics

Chemical Structure Cat. No. Product Name CAS No.
CMP-5 dihydrochloride Chemical Structure
 BCP49698 CMP-5 dihydrochloride 2309409-79-6
CMP-5 hydrochloride is a potent and selective PRMT5 inhibitor, while displays no activity against PRMT1/4/7 enzymes. It selectively blocks S2Me-H4R3 by inhibiting PRMT5 methyltransferase activity on histone preparations.
Nicotinamide riboside malate Chemical Structure
 BCP49681 Nicotinamide riboside malate 2415659-01-5
Nicotinamide riboside malate, an orally active NAD+ precursor, increases NAD+ levels and activates SIRT1 and SIRT3.
Bobcat339 Chemical Structure
 BCP31159 Bobcat339 2280037-51-4
Bobcat339 is a novel cytosine-based TET enzyme inhibitor with IC50 of 33 uM (TET1) and 73 uM (TET2).
Bobcat339 hydrochloride Chemical Structure
 BCP49654 Bobcat339 hydrochloride 2436747-44-1
Bobcat339 hydrochloride is a potent and selective cytosine-based inhibitor of TET enzyme, with the IC50s of 33 μM and 73 μM for TET1 and TET2, respectively.
QL-1200186 Chemical Structure
 BCP49631 QL-1200186 2848664-42-4
QL-1200186 is an orally active and selective TYK2 inhibitor.
MS023 dihydrochloride Chemical Structure
 BCP49591 MS023 dihydrochloride 1992047-64-9
MS023 dihydrochloride is a potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, respectively.
Olpasiran Chemical Structure
 BCP49527 Olpasiran 2225856-03-9
Olpasiran is a small interfering RNA that reduces lipoprotein(a) synthesis in the liver.
ARX-788 Chemical Structure
 BCP49232 ARX-788 2636710-07-9
ARX788 is a next-generation, site-specific anti-HER2 ADC that utilizes a unique nonnatural amino acid–enabled conjugation technology and a noncleavable Amberstatin (AS269) drug-linker to generate a homogeneous ADC with a drug-to-antibody ratio of 1.9.
Tinengotinib Chemical Structure
 BCP49223 Tinengotinib 2230490-29-4
Tinengotinib is an antineoplastic tyrosine kinase inhibitor.Tinengotinib is the modulator of one or more protein kinases such as Aurora kinase and VEGFR kinase.
Pociredir Chemical Structure
 BCP49202 Pociredir 2490674-02-5
Pociredir is an embryonic ectoderm development (EED) protein inhibitor. Pociredir can be used for the research of inflammatory or hemoglobinopathies, such as sickle cell disease.
123下一页末页共 712 条记录 1 / 72 页 
0086-13720134139